rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-18
|
pubmed:abstractText |
Allogeneic hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA)-compatible sibling donors is a potential curative treatment for hematological and non-hematological malignancies. Nevertheless, high mortality rates may be associated with this therapy, especially in older patients, those with other comorbidities or who receive a second HSCT.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0902-4441
|
pubmed:author |
pubmed-author:AltésAA,
pubmed-author:BrionesJJ,
pubmed-author:BrunetSS,
pubmed-author:CanalsCC,
pubmed-author:ConstantJJ,
pubmed-author:MartinoRR,
pubmed-author:ParodyRR,
pubmed-author:SanzM AMA,
pubmed-author:SierraJJ,
pubmed-author:SuredaAA,
pubmed-author:ValcárcelDD,
pubmed-author:VillelaS LSL
|
pubmed:copyrightInfo |
(c) Blackwell Munksgaard 2005
|
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
144-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15654906-Adolescent,
pubmed-meshheading:15654906-Adult,
pubmed-meshheading:15654906-Age Factors,
pubmed-meshheading:15654906-Aged,
pubmed-meshheading:15654906-Bone Marrow Transplantation,
pubmed-meshheading:15654906-Disease-Free Survival,
pubmed-meshheading:15654906-Female,
pubmed-meshheading:15654906-Hematologic Neoplasms,
pubmed-meshheading:15654906-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:15654906-Humans,
pubmed-meshheading:15654906-Lymphocyte Depletion,
pubmed-meshheading:15654906-Middle Aged,
pubmed-meshheading:15654906-Multivariate Analysis,
pubmed-meshheading:15654906-Risk Factors,
pubmed-meshheading:15654906-Transplantation, Autologous,
pubmed-meshheading:15654906-Transplantation, Homologous,
pubmed-meshheading:15654906-Transplantation Conditioning
|
pubmed:year |
2005
|
pubmed:articleTitle |
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
|
pubmed:affiliation |
Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|